Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

U.S. Pharma: Latest Analyst Actions
Seeking Alpha
Sunday, December 5, 2010 - 11:35am
tags:
Seattle Genetics, Incyte, Biodel, Cadence Pharmaceuticals, NeurogesX, Metabolix, Gilead Sciences, Pfizer
Sun Pharma to delist troubled US subsidiary
Business Standard, India
Saturday, December 4, 2010 - 12:55pm
tags:
Sun Pharma
Neutral Short Term Pattern on Pfizer
Trader's Huddle
Saturday, December 4, 2010 - 12:42pm
tags:
Pfizer, investors
Vertex Pharmaceuticals Announces Webcast of its Presentation at the NASDAQ OMX Investor Conference
BusinessWire
Saturday, December 4, 2010 - 12:41pm
tags:
Vertex Pharmaceuticals
QR Pharma announces FDA clearance to begin trials related to Alzheimer compound
Behavioral Health Central
Saturday, December 4, 2010 - 12:40pm
tags:
QR Pharma, Alzheimer's disease, bisnorcymserine, butyrylcholinesterase inhibition
AstraZeneca raided by EU investigators amid collusion claims
Daily Mail, UK
Saturday, December 4, 2010 - 12:35pm
tags:
AstraZeneca, Nexium
FDA: Proposed Weight Loss Drug Contrave Raises Blood Pressure
WSJ
Saturday, December 4, 2010 - 12:33pm
tags:
Takeda, Contrave, weight loss, obesity. Orexigen Therapeutics
More Than 1,000 Drug Patents Expiring During the Next Two Years: PharmaLive Special Reports
PharmaLive
Saturday, December 4, 2010 - 12:31pm
tags:
patents
Teva Pharmaceutical Industries Downward Momentum Looks to Continue (TEVA)
Benzinga
Saturday, December 4, 2010 - 12:30pm
tags:
Teva Pharmaceuticals, investors
How Cheap Is Amgen's Stock by the Numbers?
Motley Fool
Saturday, December 4, 2010 - 12:20pm
tags:
Amgen, investors
Pfizer Plans $75 Million Fund to Address Shareholder Suits
NY Times
Saturday, December 4, 2010 - 12:19pm
tags:
Pfizer, investors, lawsuits
Setback for Valeant Epilepsy Drug
Yahoo/Zacks
Saturday, December 4, 2010 - 12:18pm
tags:
Valeant Pharmaceuticals, epilepsy, ezogabine, GSK
Pfizer Plans Regulatory Submissions of Bosutinib in Chronic Myeloid Leukemia
Yahoo/PR NewsWire
Saturday, December 4, 2010 - 12:17pm
tags:
Pfizer, Bosutinib, chronic myeloid leukemia
Impax Laboratories Confirms Patent Challenge Relating to INTUNIVTM, 4 mg
Yahoo/BusinessWire
Saturday, December 4, 2010 - 12:16pm
tags:
Impax Labs, Shire Development Inc, Intuniv, ADHD
Neutral on Incyte
Yahoo/Zacks
Saturday, December 4, 2010 - 12:15pm
tags:
Incyte, investors
Pfizer Properly Warned Woman's Doctors on Prempro Health Risks, Jury Finds
Bloomberg
Saturday, December 4, 2010 - 12:14pm
tags:
Pfizer, lawsuits, Prempro
Which Drugmakers Will Take You Higher?
Minyanville
Saturday, December 4, 2010 - 12:13pm
tags:
Novartis, GSK, JNJ, Pfizer, AstraZeneca
BioCryst Reports New Data from Its Phase 2 Forodesine Study in Patients with Chronic Lymphocytic Leukemia at the 52nd Annual American Society of Hematology Meeting
Yahoo/BusinessWire
Saturday, December 4, 2010 - 12:04pm
tags:
Biocryst, Forodesine, leukemia, chronic lymphocytic leukemia
Cell Therapeutics appeals FDA decision on Pixuvir
Yahoo/AP
Saturday, December 4, 2010 - 12:02pm
tags:
Cell Therapeutics, Pixuvri, non-Hodgkin's lymphoma
Nile Therapeutics Receives NASDAQ Notice; Will Request Hearing
Yahoo/PR NewsWire
Saturday, December 4, 2010 - 12:00pm
tags:
Nile Therapeutics, investors

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.